RENOQUID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Renoquid, and when can generic versions of Renoquid launch?
Renoquid is a drug marketed by Glenwood and is included in one NDA.
The generic ingredient in RENOQUID is sulfacytine. Additional details are available on the sulfacytine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RENOQUID?
- What are the global sales for RENOQUID?
- What is Average Wholesale Price for RENOQUID?
Summary for RENOQUID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Patent Applications: | 1,927 |
| DailyMed Link: | RENOQUID at DailyMed |
US Patents and Regulatory Information for RENOQUID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenwood | RENOQUID | sulfacytine | TABLET;ORAL | 017569-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
